Latest filing published 13 Oct 2026 for Oruka Therapeutics, Inc., €95k. Read the official filing
Arjun Agarwal appears in our data through filings on Oruka Therapeutics, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 23 January 2026 to 12 October 2026, the count stands at 37 filings.
Every open-market trade on record is a sale: 26 sales worth €3.2M. No amount is published for 6 filings, which the totals therefore leave out. Other entries cover 1 share grant and 10 option exercises.
The record was last updated on 13 October 2026 with an option exercise (€45k) in Oruka Therapeutics, Inc. Typically, a trade is published a median of 1 day after it takes place. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 37 declarations